Marja-Riitta Taskinen

发表

Exploring the lipoprotein composition using Bayesian regression on serum lipidomic profiles

Matej Oresic, Aki Vehtari, Laxman Yetukuri, 2007, ISMB/ECCB.

A continuous-time adaptive particle filter for estimations under measurement time uncertainties with an application to a plasma-leucine mixed effects model

Annette Krengel, Mats Jirstrand, Martin Adiels, 2013, BMC Systems Biology.

An Immune Response Network Associated with Blood Lipid Levels

Markus Perola, Kaisa Silander, Michael Inouye, 2010, PLoS genetics.

Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel

Lale Tokgözoğlu, Ian Graham, Stephen J. Nicholls, 2017, European heart journal.

Six new loci associated with blood low-density lipoprotein cholesterol, high-density lipoprotein cholesterol or triglycerides in humans

Dolores Corella, Olle Melander, Thomas Hedner, 2008, Nature Genetics.

Novel Loci for Metabolic Networks and Multi-Tissue Expression Studies Reveal Genes for Atherosclerosis

Niku Oksala, Markus Perola, Michael Inouye, 2012, PLoS genetics.

Amerindian-specific regions under positive selection harbour new lipid variants in Latinos

Markus Perola, Markku Heliövaara, Bogdan Pasaniuc, 2014, Nature Communications.

HDL Subspecies in Young Adult Twins: Heritability and Impact of Overweight

Kirsi H. Pietiläinen, Marja-Riitta Taskinen, Matti Jauhiainen, 2009, Obesity.

New insights into the pathophysiology of dyslipidemia in type 2 diabetes.

Marja-Riitta Taskinen, J. Borén, M. Taskinen, 2015, Atherosclerosis.

Insulin resistance as predictor of the angiographic severity and extent of coronary artery disease

Marja-Riitta Taskinen, M. Nieminen, M. Taskinen, 2007, Annals of medicine.

The need for a large-scale trial of fibrate therapy in diabetes: the rationale and design of the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study. [ISRCTN64783481]

James D. Best, Marja-Riitta Taskinen, Philip J. Barter, 2004, Cardiovascular diabetology.

Overproduction of VLDL1 Driven by Hyperglycemia Is a Dominant Feature of Diabetic Dyslipidemia

Bernt Wennberg, Martin Adiels, Jukka Westerbacka, 2005, Arteriosclerosis, thrombosis, and vascular biology.

ESC/EAS Guidelines for the management of dyslipidaemias

Ian Graham, Gabriele Riccardi, Marja-Riitta Taskinen, 2017 .

Mapping and characterization of structural variation in 17,795 human genomes

Eric S. Lander, Haley J. Abel, Yeting Zhang, 2020, Nature.

The inherent accuracy of 1H NMR spectroscopy to quantify plasma lipoproteins is subclass dependent.

Kimmo Kaski, Reino Laatikainen, Károly Héberger, 2007, Atherosclerosis.

Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease

Catherine Boileau, Päivi Pajukanta, Anne Tybjærg-Hansen, 2013, European heart journal.

Predictors of and longitudinal changes in insulin sensitivity and secretion preceding onset of type 2 diabetes.

Peter Almgren, Bo Isomaa, Tiinamaija Tuomi, 2005, Diabetes.

OSBPL10, a novel candidate gene for high triglyceride trait in dyslipidemic Finnish subjects, regulates cellular lipid metabolism

Markus Perola, Leena Peltonen, Ida Surakka, 2009, Journal of Molecular Medicine.

Decrease in circulating fibroblast growth factor 21 after an oral fat load is related to postprandial triglyceride-rich lipoproteins and liver fat.

Marja-Riitta Taskinen, Taneli Raivio, Nina Lundbom, 2012, European journal of endocrinology.

Overproduction of Very Low–Density Lipoproteins Is the Hallmark of the Dyslipidemia in the Metabolic Syndrome

Martin Adiels, Marja-Riitta Taskinen, J. Borén, 2008, Arteriosclerosis, thrombosis, and vascular biology.

Diabetic dyslipidemia.

Marja-Riitta Taskinen, 2002, Atherosclerosis. Supplements.

Genomic study in Mexicans identifies a new locus for triglycerides and refines European lipid loci

Päivi Pajukanta, Marja-Riitta Taskinen, Rita M Cantor, 2013, Journal of Medical Genetics.

Fenofibrate lowers plasma triglycerides and increases LDL particle diameter in subjects with type 2 diabetes.

George Steiner, Marja-Riitta Taskinen, Juha Vakkilainen, 2002, Diabetes care.

An Integrated Understanding of the Rapid Metabolic Benefits of a Carbohydrate-Restricted Diet on Hepatic Steatosis in Humans.

Jens Nielsen, Cheng Zhang, Martin Adiels, 2018, Cell metabolism.

Detailed metabolic and genetic characterization reveals new associations for 30 known lipid loci.

Kimmo Kaski, Markus Perola, Taru Tukiainen, 2012, Human molecular genetics.

Glycemic Control Over 5 Years in 4,900 People With Type 2 Diabetes

Russell Scott, James D. Best, Merryn Voysey, 2012, Diabetes Care.

Personal model‐assisted identification of NAD+ and glutathione metabolism as intervention target in NAFLD

Jens Nielsen, Cheng Zhang, Martin Adiels, 2017, Molecular systems biology.

High Density Lipoprotein Structural Changes and Drug Response in Lipidomic Profiles following the Long-Term Fenofibrate Therapy in the FIELD Substudy

Samuel Kaski, Ilkka Huopaniemi, Laxman Yetukuri, 2011, PloS one.

Metabolic syndrome in type 1 diabetes: association with diabetic nephropathy and glycemic control (the FinnDiane study).

Merlin C. Thomas, Marja-Riitta Taskinen, Carol Forsblom, 2005, Diabetes care.

A new combined multicompartmental model for apolipoprotein B-100 and triglyceride metabolism in VLDL subfractions Published, JLR Papers in Press, October 16, 2004. DOI 10.1194/jlr.M400108-JLR200

Bernt Wennberg, Martin Adiels, Jukka Westerbacka, 2005, Journal of Lipid Research.

Cardiac steatosis associates with visceral obesity in nondiabetic obese men.

Kirsi Lauerma, Martin Adiels, Marja-Riitta Taskinen, 2013, The Journal of clinical endocrinology and metabolism.

ESC/EAS Guidelines for the management of dyslipidaemias: the Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS).

Ian Graham, Gabriele Riccardi, Eduardo Alegria, 2011, Atherosclerosis.